Caris Life Sciences holder reports 4% equity stake
Caris Life Sciences, Inc. received an updated passive ownership report from investment entities affiliated with J.H.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Caris Life Sciences, Inc. received an updated passive ownership report from investment entities affiliated with J.H. Whitney. J.H. Whitney VI, L.P., together with J.H. Whitney Equity Partners VI, LLC, and managing members Paul R. Vigano and Robert M. Williams, Jr., report beneficial ownership of 11,256,615 shares of Caris common stock.
This position represents 4.0% of the outstanding common stock, with shared voting and dispositive power over all reported shares and no sole voting or dispositive power. The filing states that no other person has the right to receive, or direct the receipt of, dividends or sale proceeds from these securities. The amendment confirms that the reporting group now holds 5 percent or less of the class.
Key Figures
Key Terms
beneficially owned financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Caris Life Sciences (CAI) does J.H. Whitney report?
Who are the reporting persons in this Caris Life Sciences (CAI) Schedule 13G/A?
What percentage of Caris Life Sciences (CAI) does the J.H. Whitney group own?
What does the '5 percent or less' disclosure mean for Caris Life Sciences (CAI)?
AI-generated analysis. How Rhea-AI works. Not financial advice.